{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:31:46Z","timestamp":1760059906796,"version":"build-2065373602"},"reference-count":59,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["HL154103","HL14285301"],"award-info":[{"award-number":["HL154103","HL14285301"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Malignant pleural effusion (MPE) can lead to pleural organization with loculation and impaired drainage. This condition is becoming increasingly more common due to advancements in cancer therapy and extended patient survival. Factors such as repeated thoracentesis through an indwelling pleural catheter (IPC), intrapleural bleeding, and tumor progression contribute to MPE organization. Loculated MPE causes breathlessness and reduced quality of life, and current therapies, including intrapleural fibrinolytic or enzymatic therapy (IPFT\/IET), have limitations in efficacy and safety. Identifying new therapeutic targets is crucial for improving treatment outcomes. Research is needed to understand the role of profibrogenic factors in pleural neoplasia, their regulation, and their impact on different stages of pleural organization. The development of a rabbit model of organizing MPE could provide insights into underlying mechanisms and novel interventions. Comparative studies of pleural tissues and effusions from MPE patients and other forms of pleural organization may reveal valuable information. Cellular and molecular profiling, assessment of biomarkers, and personalized IPFT dosing are potential areas of investigation. Suppression of PAI-1 activity and the role of hyaluronic acid in malignant mesothelioma are also important research directions. Understanding the profibrogenic capacity of pleural mesothelial cells undergoing mesenchymal transition (MesoMT) and identifying key contributors and effectors involved in this process are essential for developing effective treatments for loculated MPE.<\/jats:p>","DOI":"10.3390\/cells14141118","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T07:56:14Z","timestamp":1753084574000},"page":"1118","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Research Priorities for Malignant Pleural Organization with Loculation and Failed Drainage"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0823-3234","authenticated-orcid":false,"given":"Torry A.","family":"Tucker","sequence":"first","affiliation":[{"name":"Department of Cellular and Molecular Biology, Center for Biomedical Research, School of Medicine, The University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erminia","family":"Massarelli","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Biology, Center for Biomedical Research, School of Medicine, The University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Destarac","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Biology, Center for Biomedical Research, School of Medicine, The University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4389-2152","authenticated-orcid":false,"given":"Steven","family":"Idell","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Biology, Center for Biomedical Research, School of Medicine, The University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e35833","DOI":"10.1002\/cncr.35833","article-title":"Annual Report to the Nation on the Status of Cancer, featuring state-level statistics after the onset of the COVID-19 pandemic","volume":"131","author":"Sherman","year":"2025","journal-title":"Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/cncr.32802","article-title":"Annual report to the nation on the status of cancer, part I: National cancer statistics","volume":"126","author":"Henley","year":"2020","journal-title":"Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","article-title":"Management of Malignant Pleural Effusions. An Official ATS\/STS\/STR Clinical Practice Guideline","volume":"198","author":"Reddy","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"104749","DOI":"10.1016\/j.critrevonc.2025.104749","article-title":"Intrapleural fibrinolytic therapy for loculated malignant pleural effusion: A systematic review and meta-analysis","volume":"211","author":"Takahashi","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.3390\/curroncol31110507","article-title":"Malignant Pleural Effusion: Diagnosis and Treatment-Up-to-Date Perspective","volume":"31","author":"Orlandi","year":"2024","journal-title":"Curr. Oncol."},{"key":"ref_6","first-page":"1189","article-title":"Chinese expert consensus on treatment of malignant pleural effusion (2023 Edition)","volume":"46","author":"Society","year":"2023","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/cts.13430","article-title":"Incidence of complications from indwelling pleural catheter for pleural effusion: A meta-analysis","volume":"16","author":"Wang","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/LBR.0000000000000871","article-title":"Combination Tissue Plasminogen Activator and DNase for Loculated Malignant Pleural Effusions: A Single-center Retrospective Review","volume":"30","author":"Chan","year":"2023","journal-title":"J. Bronchol. Interv. Pulmonol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e236116","DOI":"10.1136\/bcr-2020-236116","article-title":"Successful treatment of a complex malignant pleural effusion with 1 mg alteplase instilled through a non-draining indwelling pleural catheter","volume":"14","author":"Faisal","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1200\/OP.24.00387","article-title":"Current Trends in Treating Malignant Pleural Effusion: Evidence, Guidelines, and Best Practice Recommendations","volume":"21","author":"Munavvar","year":"2024","journal-title":"JCO Oncol. Pract."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"100349","DOI":"10.1016\/j.opresp.2024.100349","article-title":"Malignant Pleural Effusion: A Multidisciplinary Approach","volume":"6","author":"Porcel","year":"2024","journal-title":"Open Respir. Arch."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13665-018-0194-3","article-title":"Management of Septated Malignant Pleural Effusions","volume":"7","author":"Banka","year":"2018","journal-title":"Curr. Pulmonol. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1007\/s00268-017-4420-x","article-title":"Early Management of Retained Hemothorax in Blunt Head and Chest Trauma","volume":"42","author":"Huang","year":"2018","journal-title":"World J. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.amjsurg.2020.11.032","article-title":"Management of simple and retained hemothorax: A practice management guideline from the Eastern Association for the Surgery of Trauma","volume":"221","author":"Patel","year":"2021","journal-title":"Am. J. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1378\/chest.118.4.1158","article-title":"Medical and surgical treatment of parapneumonic effusions: An evidence-based guideline","volume":"118","author":"Colice","year":"2000","journal-title":"Chest"},{"key":"ref_16","first-page":"283","article-title":"CT findings of diffuse pleural disease--alteration of pleura and extrapleural fat","volume":"53","author":"Ashizawa","year":"1993","journal-title":"Nihon Igaku Hoshasen Gakkai Zasshi"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e000368","DOI":"10.1136\/bmjresp-2018-000368","article-title":"MesoTRAP: A feasibility study that includes a pilot clinical trial comparing video-assisted thoracoscopic partial pleurectomy decortication with indwelling pleural catheter in patients with trapped lung due to malignant pleural mesothelioma designed to address recruitment and randomisation uncertainties and sample size requirements for a phase III trial","volume":"6","author":"Matthews","year":"2019","journal-title":"BMJ Open Respir. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1177\/00031348251331281","article-title":"Pleural Space Diseases and Their Management: What is the Role of Intrapleural Fibrinolytic Therapy?","volume":"91","author":"Siddiqui","year":"2025","journal-title":"Am. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"L757","DOI":"10.1152\/ajplung.00501.2017","article-title":"Fibrin turnover and pleural organization: Bench to bedside","volume":"314","author":"Komissarov","year":"2018","journal-title":"Am. J. Physiol. Lung. Cell. Mol. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-0039-1687908","article-title":"Tumors: Wounds That Do Not Heal-A Historical Perspective with a Focus on the Fundamental Roles of Increased Vascular Permeability and Clotting","volume":"45","author":"Dvorak","year":"2019","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00046905","article-title":"Fibrin as a component of the tumor stroma: Origins and biological significance","volume":"2","author":"Dvorak","year":"1983","journal-title":"Cancer Metastasis Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1164\/ajrccm\/140.4.1104","article-title":"Leaky vessels, fibrin deposition, and fibrosis: A sequence of events common to solid tumors and to many other types of disease","volume":"140","author":"Brown","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1172\/JCI102046","article-title":"The Effect in Patients of Streptococcal Fibrinolysin (Streptokinase) and Streptococcal Desoxyribonuclease on Fibrinous, Purulent, and Sanguinous Pleural Exudations","volume":"28","author":"Tillett","year":"1949","journal-title":"J. Clin. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0096-5588(20)31176-4","article-title":"The use of streptokinase-streptodornase in the treatment of chronic empyema; with an interpretive discussion of enzymatic actions in the field of intrathoracic diseases","volume":"21","author":"Tillett","year":"1951","journal-title":"J. Thorac. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.chest.2024.04.005","article-title":"Neutrophil-Mediated Inflammatory Plasminogen Degradation, Rather Than High Plasminogen-Activator Inhibitor-1, May Underly Failures and Inefficiencies of Intrapleural Fibrinolysis","volume":"167","author":"Barrett","year":"2025","journal-title":"Chest"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1164\/ajrccm.151.2.7842213","article-title":"Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease","volume":"151","author":"Strange","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12931-019-1204-x","article-title":"Chemical pleurodesis\u2013a review of mechanisms involved in pleural space obliteration","volume":"20","author":"Mierzejewski","year":"2019","journal-title":"Respir. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1183\/09031936.97.10071648","article-title":"Pleurodesis: State of the art","volume":"10","author":"Antony","year":"1997","journal-title":"Eur. Respir. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000335419","article-title":"Mechanisms of pleurodesis","volume":"83","year":"2012","journal-title":"Respiration"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7754\/Clin.Lab.2024.240757","article-title":"Pleural Fluid Amino Acids Contribute to Distinguishing Tuberculosis, Malignant, and Parapneumonic Pleural Effusion Patients","volume":"71","author":"Yu","year":"2025","journal-title":"Clin. Lab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/mas.21612","article-title":"Multiomic Patterns in Body Fluids: Technological Challenge with a Great Potential to Implement the Advanced Paradigm of 3p Medicine","volume":"39","author":"Gerner","year":"2020","journal-title":"Mass Spectrom. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1607-551X(08)70007-X","article-title":"Epigenetic changes in tumor suppressor genes, P15, P16, APC-3 and E-cadherin in body fluid","volume":"23","author":"Chen","year":"2007","journal-title":"Kaohsiung J. Med Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa1012740","article-title":"Intrapleural use of tissue plasminogen activator and DNase in pleural infection","volume":"365","author":"Rahman","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"127470","DOI":"10.1172\/jci.insight.127470","article-title":"Phase 1 trial of intrapleural LTI-01; single chain urokinase in complicated parapneumonic effusions or empyema","volume":"5","author":"Beckert","year":"2019","journal-title":"JCI Insight"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1590\/S1807-59322009000900010","article-title":"Does the evaluation of coagulation factors contribute to etiological diagnosis of pleural effusions?","volume":"64","author":"Vaz","year":"2009","journal-title":"Clinics"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1378\/chest.123.4.1188","article-title":"Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion","volume":"123","author":"Chung","year":"2003","journal-title":"Chest"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1183\/13993003.00349-2018","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"52","author":"Bibby","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/JTO.0b013e318189f53d","article-title":"Diagnostic and prognostic implications of pleural adhesions in malignant effusions","volume":"3","author":"Bielsa","year":"2008","journal-title":"J. Thorac. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Addala, D.N., Kanellakis, N.I., Bedawi, E.O., Dong, T., and Rahman, N.M. (2022). Malignant pleural effusion: Updates in diagnosis, management and current challenges. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1053574"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12931-024-02684-7","article-title":"Malignant pleural effusion: Current understanding and therapeutic approach","volume":"25","author":"Gonnelli","year":"2024","journal-title":"Respir. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1164\/rccm.201704-0809OC","article-title":"Randomized Controlled Trial of Urokinase versus Placebo for Nondraining Malignant Pleural Effusion","volume":"197","author":"Mishra","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1378\/chest.14-2401","article-title":"Intrapleural Fibrinolysis for the Treatment of Indwelling Pleural Catheter-Related Symptomatic Loculations: A Multicenter Observational Study","volume":"148","author":"Thomas","year":"2015","journal-title":"Chest"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e00457","DOI":"10.1002\/rcr2.457","article-title":"Very low-dose intrapleural tPA for indwelling pleural catheter-associated symptomatic fluid loculation","volume":"7","author":"Lan","year":"2019","journal-title":"Respirol. Case Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1159\/000514643","article-title":"Intrapleural Fibrinolytics and Deoxyribonuclease for Treatment of Indwelling Pleural Catheter-Related Pleural Infection: A Multi-Center Observational Study","volume":"100","author":"Fitzgerald","year":"2021","journal-title":"Respiration"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1513\/AnnalsATS.201711-848PS","article-title":"Intrapleural Fibrinolytic Therapy for Empyema and Pleural Loculation: Knowns and Unknowns","volume":"15","author":"Idell","year":"2018","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1556-0864(15)31612-9","article-title":"Intrapleural urokinase for the treatment of loculated malignant pleural effusions and trapped lungs in medically inoperable cancer patients","volume":"1","author":"Hsu","year":"2006","journal-title":"J. Thorac. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1513\/AnnalsATS.201609-673OC","article-title":"Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project","volume":"14","author":"Popowicz","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"De Vera, C.J., Jacob, J., Sarva, K., Christudas, S., Emerine, R.L., Florence, J.M., Akiode, O., Gorthy, T.V., Tucker, T.A., and Singh, K.P. (2024). Intrapleural Fibrinolytic Interventions for Retained Hemothoraces in Rabbits. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25168778"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/CBM-210280","article-title":"Profile of soluble factors in pleural effusions predict prognosis in mesothelioma","volume":"33","author":"Dick","year":"2022","journal-title":"Cancer Biomark."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s40425-019-0590-4","article-title":"Treatment of malignant pleural effusions: The case for localized immunotherapy","volume":"7","author":"Donnenberg","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1164\/rccm.201911-2169OC","article-title":"Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions","volume":"201","author":"Arnold","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1164\/rccm.202206-1084OC","article-title":"The Biological Role of Pleural Fluid PAI-1 and Sonographic Septations in Pleural Infection: Analysis of a Prospectively Collected Clinical Outcome Study","volume":"207","author":"Bedawi","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1165\/rcmb.2014-0168OC","article-title":"Targeting of plasminogen activator inhibitor 1 improves fibrinolytic therapy for tetracycline-induced pleural injury in rabbits","volume":"52","author":"Florova","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e00694","DOI":"10.1002\/rcr2.694","article-title":"Hyaluronic acid in viscous malignant mesothelioma pleural effusion","volume":"9","author":"Cheah","year":"2021","journal-title":"Respirol. Case Rep."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Shojaee, S., Romano, G., Sanchez, T.M., Yermakhanova, G., Saviana, M., Le, P., Nigita, G., Calore, F., Guthrie, R., and Hess, K. (2022). Extracellular Vesicle MicroRNA in Malignant Pleural Effusion. Genes, 13.","DOI":"10.3390\/genes13112159"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"L419","DOI":"10.1152\/ajplung.00271.2023","article-title":"Myocardin regulates fibronectin expression and secretion from human pleural mesothelial cells","volume":"326","author":"Sakai","year":"2024","journal-title":"Am. J. Physiol. Lung. Cell. Mol. Physiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"L353","DOI":"10.1152\/ajplung.00251.2023","article-title":"Role of ZIP kinase in development of myofibroblast differentiation from HPMCs","volume":"326","author":"Choo","year":"2024","journal-title":"Am. J. Physiol. Lung. Cell. Mol. Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1165\/rcmb.2023-0131OC","article-title":"The mTORC2\/SGK1\/NDRG1 Signaling Axis Is Critical for the Mesomesenchymal Transition of Pleural Mesothelial Cells and the Progression of Pleural Fibrosis","volume":"70","author":"Keshava","year":"2024","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Jeffers, A., Owens, S., Qin, W., Durojaye, O., Florence, M., Okeke, P., Destarac, L., Keshava, S., Ikebe, M., and Idell, S. (2025). The Role of Tuftelin-1 in Mesomesenchymal Transition of Pleural Mesothelial Cells and the Progression of Pleural Fibrosis. Am. J. Respir. Cell Mol. Biol.","DOI":"10.1165\/rcmb.2024-0263OC"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/14\/1118\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:13:07Z","timestamp":1760033587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/14\/1118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":59,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["cells14141118"],"URL":"https:\/\/doi.org\/10.3390\/cells14141118","relation":{},"ISSN":["2073-4409"],"issn-type":[{"type":"electronic","value":"2073-4409"}],"subject":[],"published":{"date-parts":[[2025,7,21]]}}}